Putnam Investments »

Marinus Pharmaceuticals shares owned by Putnam Investments

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Putnam Investments from 13F filings

Historical chart of Putnam Investments investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Putnam Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Putnam Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $416k 52k 8.05

More positions owned by Putnam Investments

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Exxon Mobil Corp Common Stock (XOM)
Meta Platforms Common Stock (META)
Oracle Corp Common Stock (ORCL)
Walmart Common Stock (WMT)
Alphabet Common Stock (GOOG)
Regeneron Pharmaceuticals Common Stock (REGN)
Bank Of America Corp Common Stock (BAC)
Eli Lilly & Co Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Mckesson Corp Common Stock (MCK)
Merck & Co Common Stock (MRK)

View all positions for Putnam Investments

Top funds holding Marinus Pharmaceuticals

Eventide Asset Management
Franklin Resources
Cormorant Asset Management
venBio Select Advisor
Jennison Associates
Vanguard Group
Lion Point Capital
Bleichroeder
GMT Capital Corp
Ikarian Capital
Citadel Advisors
Opaleye Management
Standard Life Aberdeen
Point72 Asset Management
Superstring Capital Management

View all funds holding Marinus Pharmaceuticals